ABP 938 is an Amgen Inc program. Its next catalyst is a Readout in Jul 2027. Every date links its source.
All upcoming FDA decision dates on the 2026 PDUFA calendar
Sponsor: Amgen Inc (AMGN). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.
The next tracked catalyst for ABP 938 is a Readout in Jul 2027.
No FDA decision for ABP 938 is in our archive yet.
Amgen Inc (AMGN).
FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.